Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 8, 2010, Pages 1481-1489

  Dimitrakopoulou Strauss, Antonia ^a   Strauss, Ludwig G ^a   Egerer, Gerlinde ^b   Vasamiliette, Julie ^a   Schmitt, Thomas ^b   Haberkorn, Uwe ^a,b   Kasper, Bernd ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

18F FDG; Kinetic modelling; Prognosis; Sarcomas; Therapy monitoring

Indexed keywords

DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; IFOSFAMIDE;

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FOLLOW UP; HUMAN; METASTASIS; MULTIPLE CYCLE TREATMENT; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSITRON EMISSION TOMOGRAPHY; SOFT TISSUE SARCOMA; TREATMENT OUTCOME;

DISCRIMINANT ANALYSIS; DOXORUBICIN; DRUG THERAPY, COMBINATION; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; NEOPLASM METASTASIS; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; RISK; SARCOMA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77956184902     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1435-z     Document Type: Article

References (18)

1. http://www.cancer.gov/cancertopics/factsheet/sites-types/ soft-tissue-sarcoma
2. SR Grobmyer RG Maki GD Demetri M Mazumdar E Riedel MF Brennan, et al. 2004 Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma Ann Oncol 15 1667 1672 10.1093/annonc/mdh431 1:STN:280: DC%2BD2crkslSktw%3D%3D 15520069
3. LG Strauss PS Conti 1991 The applications of PET in clinical oncology J Nucl Med 32 623 648 1:STN:280:DyaK3M7ptlyjsA%3D%3D 2013803
4. C Burger A Buck 1997 Requirements and implementation of a flexible kinetic modeling tool J Nucl Med 38 1818 1823 1:STN:280:DyaK1c%2FktVGhsg%3D%3D 9374364
5. K Mikolajczyk M Szabatin P Rudnicki M Grodzki C Burger 1998 A JAVA environment for medical image data analysis: initial application for brain PET quantitation Med Inform (Lond) 23 207 214 10.3109/14639239809001400 1:STN:280:DyaK1M%2FgtFGjsw%3D%3D
6. A Dimitrakopoulou-Strauss M Hoffmann R Bergner M Uppenkamp M Eisenhut L Pan, et al. 2007 Prediction of short-term survival in patients with advanced nonsmall cell lung cancer following chemotherapy based on 2-deoxy-2-[F-18] fluoro-D-glucose-positron emission tomography: a feasibility study Mol Imaging Biol 9 308 317 10.1007/s11307-007-0103-6 17623254
7. H Miyazawa A Osmont MC Petit-Taboué I Tillet JM Travère AR Young, et al. 1993 Determination of 18F-fluoro-2-deoxy-D-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography J Neurosci Methods 50 263 272 10.1016/0165-0270(93)90033-N 1:CAS:528:DyaK2cXjtFygsbk%3D 8152238
8. Sokoloff L, Smith CB. Basic principles underlying radioisotopic methods for assay of biochemical processes in vivo. In: Greitz T, Ingvar DH, Widén L, editors. The metabolism of the human brain studied with positron emission tomography. New York: Raven; 1983. p. 123-48.
9. T Ohtake N Kosaka T Watanabe I Yokoyama T Moritan M Masuo, et al. 1991 Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs J Nucl Med 32 1432 1438 1:STN:280:DyaK3M3psV2jtg%3D%3D 2066802
10. A Dimitrakopoulou-Strauss LG Strauss K Mikolajczyk C Burger T Lehnert L Bernd, et al. 2003 On the fractal nature of dynamic positron emission tomography (PET) studies World J Nucl Med 4 306 313
11. MH Schwarzbach U Hinz A Dimitrakopoulou-Strauss F Willeke S Cardona G Mechtersheimer, et al. 2005 Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas Ann Surg 241 286 294 10.1097/01.sla. 0000152663.61348.6f 15650639
12. B Kasper T Schmitt P Wuchter A Dimitrakopoulou-Strauss AD Ho G Egerer 2009 The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin Mar Drugs 7 331 340 10.3390/md7030331 1:CAS:528:DC%2BD1MXhsVWktrfF 19841717
13. MR Benz MS Allen-Auerbach FC Eilber HJ Chen ME Phelps J Czernin, et al. 2008 Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas J Nucl Med 49 1579 1584 10.2967/jnumed.108.053694 18794268
14. V Evilevitch WA Weber WD Tap M Allen-Auerbach K Chow SD Nelson, et al. 2008 Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas Clin Cancer Res 14 715 720 10.1158/1078-0432.CCR-07-1762 1:CAS:528:DC%2BD1cXhsFyktro%3D 18245531
15. LG Strauss D Koczan S Klippel L Pan C Cheng S Willis, et al. 2008 Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors J Nucl Med 49 1238 1244 10.2967/jnumed.108.051599 1:CAS:528:DC%2BD1cXhtVCqs73P 18632818
16. SM Schuetze BP Rubin C Vernon DS Hawkins JD Bruckner EU Conrad, et al. 2005 Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy Cancer 103 339 348 10.1002/cncr.20769 15578712
17. A Dimitrakopoulou-Strauss LG Strauss C Burger A Rühl G Irngartinger W Stremmel, et al. 2004 Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy J Nucl Med 45 1480 1487 1:CAS:528:DC%2BD2cXosVWis7o%3D 15347714
18. R Boellaard NC Krak OS Hoekstra AA Lammertsma 2004 Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study J Nucl Med 45 1519 1527 15347719